Infectious cDNA clone of the RA27/3 vaccine strain of Rubella virus

被引:18
作者
Pugachev, KV
Galinski, MS
Frey, TK
机构
[1] Georgia State Univ, Dept Biol, Atlanta, GA 30303 USA
[2] Merck & Co Inc, Merck Mfg Div, W Point, PA 19486 USA
关键词
D O I
10.1006/viro.2000.0408
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Rubella virus (RUB), a small plus-strand RNA virus, is a significant human pathogen. The RA27/3 vaccine strain of RUB is one of the most successful live attenuated vaccines developed. In this article, we report the construction of an RA27/3 infectious clone, a complete cDNA copy of the RA27/3 genome that can be transcribed in vitro to generate infectious RNA molecules. Virus generated from such in vitro transcripts was phenotypically similar to RA27/3 virus. To investigate the attenuation of the RA27/3 strain, a series of chimeras was made by the insertion of different fragments of the RA27/3 genome into an infectious clone based on the Therien wild-type strain of RUB. Analysis of the resulting chimeric viruses revealed that the pattern of RA27/3 attenuation in cell culture is complex: attenuating elements in the RA27/3 genome were found in the 5' untranslated region (UTR), a region of the nonstructural proteins containing the protease motif and the capsid gene. Within the 5' UTR, the attenuation determinant was mapped to nt 7 Surprisingly, these analyses also revealed a potentiating mutation at nt 164 of the RA27/3 genome. Although this determinant was within the coding sequences of the nonstructural proteins, the encoded amino acid had no effect on cell culture phenotype and thus the determinant may operate at the level of RNA structure. In addition to investigation of the mechanisms of RA27/3 attenuation, the availability of the RA27/3 infectious clone offers the opportunity for strict genetic control over RUB vaccine manufacturing, for development of novel DNA-based vaccines against RUB, and for development of recombinant RUB vaccines that also target other diseases. (C) 2000 Academic Press.
引用
收藏
页码:189 / 197
页数:9
相关论文
共 26 条
[1]  
[Anonymous], 1999, VACCINES-BASEL
[2]   DETERMINANTS OF ATTENUATION AND TEMPERATURE SENSITIVITY IN THE TYPE-1 POLIOVIRUS SABIN VACCINE [J].
BOUCHARD, MJ ;
LAM, DH ;
RACANIELLO, VR .
JOURNAL OF VIROLOGY, 1995, 69 (08) :4972-4978
[3]   SEQUENCE OF THE GENOME RNA OF RUBELLA-VIRUS - EVIDENCE FOR GENETIC REARRANGEMENT DURING TOGAVIRUS EVOLUTION [J].
DOMINGUEZ, G ;
WANG, CY ;
FREY, TK .
VIROLOGY, 1990, 177 (01) :225-238
[4]   Molecular and biological changes associated with HeLa cell attenuation of wild-type yellow fever virus [J].
Dunster, LM ;
Wang, HM ;
Ryman, KD ;
Miller, BR ;
Watowich, SJ ;
Minor, PD ;
Barrett, ADT .
VIROLOGY, 1999, 261 (02) :309-318
[5]   IDENTIFICATION OF THE RUBELLA-VIRUS NONSTRUCTURAL PROTEINS [J].
FORNG, RY ;
FREY, TK .
VIROLOGY, 1995, 206 (02) :843-853
[6]   MOLECULAR-BIOLOGY OF RUBELLA-VIRUS [J].
FREY, TK .
ADVANCES IN VIRUS RESEARCH, VOL 44, 1994, 44 :69-160
[7]   Molecular analysis of rubella virus epidemiology across three continents, North America, Europe, and Asia, 1961-1997 [J].
Frey, TK ;
Abernaty, ES ;
Bosma, TJ ;
Starkey, WG ;
Corbett, KM ;
Best, JM ;
Katow, S ;
Weaver, SC .
JOURNAL OF INFECTIOUS DISEASES, 1998, 178 (03) :642-650
[8]   The yellow fever 17D vaccine virus: Molecular basis of viral attenuation and its use as an expression vector [J].
Galler, R ;
Freire, MS ;
Jabor, AV ;
Mann, GF .
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 1997, 30 (02) :157-168
[9]   Genetic variability among yellow fever virus 17D substrains [J].
Galler, R ;
Post, PR ;
Santos, CND ;
Ferreira, II .
VACCINE, 1998, 16 (9-10) :1024-1028
[10]   TIME COURSE OF VIRUS-SPECIFIC MACROMOLECULAR-SYNTHESIS DURING RUBELLA-VIRUS INFECTION IN VERO CELLS [J].
HEMPHILL, ML ;
FORNG, RY ;
ABERNATHY, ES ;
FREY, TK .
VIROLOGY, 1988, 162 (01) :65-75